These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25247654)

  • 1. Advances in molecular markers of germ cell cancer in patients with disorders of sex development.
    van der Zwan YG; Cools M; Looijenga LH
    Endocr Dev; 2014; 27():172-84. PubMed ID: 25247654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model.
    van der Zwan YG; Biermann K; Wolffenbuttel KP; Cools M; Looijenga LH
    Eur Urol; 2015 Apr; 67(4):692-701. PubMed ID: 25240975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers.
    Cools M; Drop SL; Wolffenbuttel KP; Oosterhuis JW; Looijenga LH
    Endocr Rev; 2006 Aug; 27(5):468-84. PubMed ID: 16735607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadal development and tumor formation at the crossroads of male and female sex determination.
    Cools M; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Looijenga LH
    Sex Dev; 2011; 5(4):167-80. PubMed ID: 21791949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing the risk of germ cell tumourigenesis in disorders of sex development patients.
    Cools M; Looijenga LH; Wolffenbuttel KP; T'Sjoen G
    Endocr Dev; 2014; 27():185-96. PubMed ID: 25247655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biology of germ cell tumors in disorders of sex development.
    Hersmus R; van Bever Y; Wolffenbuttel KP; Biermann K; Cools M; Looijenga LH
    Clin Genet; 2017 Feb; 91(2):292-301. PubMed ID: 27716895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor risk and clinical follow-up in patients with disorders of sex development.
    Cools M; Looijenga LH
    Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():519-24. PubMed ID: 22423509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development.
    Pyle LC; Nathanson KL
    Am J Med Genet C Semin Med Genet; 2017 Jun; 175(2):304-314. PubMed ID: 28544305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor risk in disorders of sex development.
    Pleskacova J; Hersmus R; Oosterhuis JW; Setyawati BA; Faradz SM; Cools M; Wolffenbuttel KP; Lebl J; Drop SL; Looijenga LH
    Sex Dev; 2010 Sep; 4(4-5):259-69. PubMed ID: 20558977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadal tumours and DSD.
    Looijenga LH; Hersmus R; de Leeuw BH; Stoop H; Cools M; Oosterhuis JW; Drop SL; Wolffenbuttel KP
    Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):291-310. PubMed ID: 20541153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germ cell cancer risk in DSD patients.
    Cools M
    Ann Endocrinol (Paris); 2014 May; 75(2):67-71. PubMed ID: 24786700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germ cell tumor showing partial trisomy 1 in a gonadectomized intersex child with monosomy X and double Y mosaicism.
    Ogur G; Pinarli FG; Dağdemir A; Artan S; Artürk E; Elli M; Sezer OT; Okten G
    J Pediatr Hematol Oncol; 2006 Nov; 28(11):750-4. PubMed ID: 17114963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor risk in disorders of sex development (DSD).
    Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP
    Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic analysis of bilateral ovarian germ cell tumors.
    Hennes E; Zahn S; Lopes LF; Schönberger S; Leuschner I; Göbel U; Calaminus G; Schneider DT
    Klin Padiatr; 2012 Oct; 224(6):359-65. PubMed ID: 23143763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance.
    Looijenga LH; Gillis AJ; Stoop H; Biermann K; Oosterhuis JW
    Int J Androl; 2011 Aug; 34(4 Pt 2):e234-51. PubMed ID: 21564133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of epigenetics in the etiology of germ cell cancer.
    Van Der Zwan YG; Stoop H; Rossello F; White SJ; Looijenga LH
    Int J Dev Biol; 2013; 57(2-4):299-308. PubMed ID: 23784841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of tumor markers in germ cell malignancies.
    Bosl GJ; Chaganti RS
    Hematol Oncol Clin North Am; 1994 Jun; 8(3):573-87. PubMed ID: 8707773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD).
    Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH
    Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the pathology and classification of gonadal neoplasms composed of germ cells and sex cord derivatives.
    Talerman A; Roth LM
    Int J Gynecol Pathol; 2007 Jul; 26(3):313-21. PubMed ID: 17581418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadal malignancy in 13 consecutive collected patients with disorders of sex development (DSD) from Semarang (Indonesia).
    Juniarto AZ; Setyawati BA; Miranti IP; Santosa A; Hersmus R; Stoop H; Cools M; Oosterhuis JW; Drop SL; Faradz SM; Looijenga LH
    J Clin Pathol; 2013 Mar; 66(3):198-204. PubMed ID: 23268320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.